JP2014513122A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513122A5 JP2014513122A5 JP2014509340A JP2014509340A JP2014513122A5 JP 2014513122 A5 JP2014513122 A5 JP 2014513122A5 JP 2014509340 A JP2014509340 A JP 2014509340A JP 2014509340 A JP2014509340 A JP 2014509340A JP 2014513122 A5 JP2014513122 A5 JP 2014513122A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- carboxamide
- dihydroisoxazol
- methoxybenzyl
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 benzo [1,4] oxazin-3-oneyl Chemical group 0.000 claims 203
- HKSQZEGSMBFHGC-UHFFFAOYSA-N pyrimidine-4-carboxamide Chemical compound NC(=O)C1=CC=NC=N1 HKSQZEGSMBFHGC-UHFFFAOYSA-N 0.000 claims 45
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 22
- 125000004076 pyridyl group Chemical group 0.000 claims 21
- 125000001544 thienyl group Chemical group 0.000 claims 17
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 15
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 15
- 125000003226 pyrazolyl group Chemical group 0.000 claims 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 12
- 125000002757 morpholinyl group Chemical group 0.000 claims 12
- 125000002098 pyridazinyl group Chemical group 0.000 claims 12
- 125000000984 3-chloro-4-fluorobenzyl group Chemical group [H]C1=C(F)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 11
- 125000002883 imidazolyl group Chemical group 0.000 claims 11
- 125000000842 isoxazolyl group Chemical group 0.000 claims 11
- 125000005494 pyridonyl group Chemical group 0.000 claims 11
- 150000003857 carboxamides Chemical class 0.000 claims 10
- 125000002971 oxazolyl group Chemical group 0.000 claims 10
- 125000003386 piperidinyl group Chemical group 0.000 claims 10
- 125000006509 3,4-difluorobenzyl group Chemical group [H]C1=C(F)C(F)=C([H])C(=C1[H])C([H])([H])* 0.000 claims 9
- 125000002393 azetidinyl group Chemical group 0.000 claims 9
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 9
- 125000000168 pyrrolyl group Chemical group 0.000 claims 9
- 125000003831 tetrazolyl group Chemical group 0.000 claims 9
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 9
- 125000001425 triazolyl group Chemical group 0.000 claims 9
- 125000005940 1,4-dioxanyl group Chemical group 0.000 claims 8
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 8
- 125000001786 isothiazolyl group Chemical group 0.000 claims 8
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 8
- 125000003373 pyrazinyl group Chemical group 0.000 claims 8
- 125000000335 thiazolyl group Chemical group 0.000 claims 8
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 7
- 229910052794 bromium Inorganic materials 0.000 claims 7
- 229910052801 chlorine Inorganic materials 0.000 claims 7
- 229910052731 fluorine Inorganic materials 0.000 claims 7
- 125000002541 furyl group Chemical group 0.000 claims 7
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 claims 7
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 7
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 6
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 6
- SSFPLTJTUJJJML-UHFFFAOYSA-N OC(=O)C(F)(F)F.NC(=O)C1=CC=NC=N1 Chemical compound OC(=O)C(F)(F)F.NC(=O)C1=CC=NC=N1 SSFPLTJTUJJJML-UHFFFAOYSA-N 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 125000004193 piperazinyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- VUMINWLDNHKRNZ-PUCZYUMASA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 VUMINWLDNHKRNZ-PUCZYUMASA-N 0.000 claims 5
- 125000001624 naphthyl group Chemical group 0.000 claims 5
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 5
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 claims 4
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 4
- 125000005605 benzo group Chemical group 0.000 claims 4
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 4
- 125000005874 benzothiadiazolyl group Chemical group 0.000 claims 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 4
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 4
- 125000001041 indolyl group Chemical group 0.000 claims 4
- VUMINWLDNHKRNZ-WVFSVQOHSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 VUMINWLDNHKRNZ-WVFSVQOHSA-N 0.000 claims 4
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 4
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 3
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 claims 3
- POCGPTVKWWVDHU-CAYVGHNUSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@H](CO)CO1 POCGPTVKWWVDHU-CAYVGHNUSA-N 0.000 claims 3
- VUMINWLDNHKRNZ-XMDBHEJHSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 VUMINWLDNHKRNZ-XMDBHEJHSA-N 0.000 claims 3
- RSJSHDKJJMWRIK-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-(6-methoxypyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N1=NC(OC)=CC=C1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 RSJSHDKJJMWRIK-UHFFFAOYSA-N 0.000 claims 3
- 125000004306 triazinyl group Chemical group 0.000 claims 3
- DCOFGLGEIUURAQ-SLFFLAALSA-N (2r,5s)-5-[(5s)-3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]-1,4-dioxane-2-carboxylic acid Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@H]2OC[C@@H](OC2)C(O)=O)=C1 DCOFGLGEIUURAQ-SLFFLAALSA-N 0.000 claims 2
- DCOFGLGEIUURAQ-ZCNNSNEGSA-N (2s,5r)-5-[(5s)-3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]-1,4-dioxane-2-carboxylic acid Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@H](OC2)C(O)=O)=C1 DCOFGLGEIUURAQ-ZCNNSNEGSA-N 0.000 claims 2
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 claims 2
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 2
- DRYMMXUBDRJPDS-UHFFFAOYSA-N 2-hydroxy-2-methylpropanamide Chemical compound CC(C)(O)C(N)=O DRYMMXUBDRJPDS-UHFFFAOYSA-N 0.000 claims 2
- UPCUZOMSXKDEHA-UHFFFAOYSA-N 6-(5-cyclohexyl-4,5-dihydro-1,2-oxazol-3-yl)-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C2CCCCC2)=NC(C)=N1 UPCUZOMSXKDEHA-UHFFFAOYSA-N 0.000 claims 2
- BSUOXCWNKFVSGN-JOCHJYFZSA-N 6-[(5r)-5-(1-cyclopropyl-6-oxopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)C2=NN(C(=O)C=C2)C2CC2)=C1 BSUOXCWNKFVSGN-JOCHJYFZSA-N 0.000 claims 2
- KHBLMURYLWZVDR-QFIPXVFZSA-N 6-[(5s)-5-(1-cyclopropyl-6-oxopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)C2=CN(C(=O)C=C2)C2CC2)=C1 KHBLMURYLWZVDR-QFIPXVFZSA-N 0.000 claims 2
- OPDVFTMQUKTRKY-KBJGYGKASA-N 6-[(5s)-5-[(2r,5r)-5-(acetamidomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-chloro-4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](CNC(=O)C)CO[C@H]1[C@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(Cl)C(F)=CC=2)C1 OPDVFTMQUKTRKY-KBJGYGKASA-N 0.000 claims 2
- UDHYUGQMJBTKLS-UZFJHSOTSA-N 6-[(5s)-5-[(2r,5r)-5-(acetamidomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(C)=O)OC2)=C1 UDHYUGQMJBTKLS-UZFJHSOTSA-N 0.000 claims 2
- NGJASFSHNCVYCP-MQNAVGNWSA-N 6-[(5s)-5-[(2r,5r)-5-(acetamidomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methylphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](CNC(=O)C)CO[C@H]1[C@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(C)C(F)=CC=2)C1 NGJASFSHNCVYCP-MQNAVGNWSA-N 0.000 claims 2
- QNCKHTIYGBLLDT-UZFJHSOTSA-N 6-[(5s)-5-[(2r,5r)-5-[(dimethylcarbamoylamino)methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)N(C)C)OC2)=C1 QNCKHTIYGBLLDT-UZFJHSOTSA-N 0.000 claims 2
- UZLVHEAEQBVOHA-UZFJHSOTSA-N 6-[(5s)-5-[(2r,5r)-5-[[(2-cyanoacetyl)amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)CC#N)OC2)=C1 UZLVHEAEQBVOHA-UZFJHSOTSA-N 0.000 claims 2
- WUUFRYFCEHCEQV-ZCNNSNEGSA-N 6-[(5s)-5-[(2r,5s)-5-carbamoyl-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@H](OC2)C(N)=O)=C1 WUUFRYFCEHCEQV-ZCNNSNEGSA-N 0.000 claims 2
- KHBLMURYLWZVDR-UHFFFAOYSA-N 6-[5-(1-cyclopropyl-6-oxopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(C(=O)C=C2)C2CC2)=C1 KHBLMURYLWZVDR-UHFFFAOYSA-N 0.000 claims 2
- VZTBAFBSCXVKCE-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3,4-difluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N=1C(C)=NC(C(=O)NCC=2C=C(F)C(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 VZTBAFBSCXVKCE-UHFFFAOYSA-N 0.000 claims 2
- MIMNGOFKWLSVIZ-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methylphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=C(C)C(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 MIMNGOFKWLSVIZ-UHFFFAOYSA-N 0.000 claims 2
- QETOABANHONNPR-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=CC(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 QETOABANHONNPR-UHFFFAOYSA-N 0.000 claims 2
- ZEHSQVFSYSGUMS-UHFFFAOYSA-N 6-[5-[1-(2-acetamidoacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CNC(C)=O)=C1 ZEHSQVFSYSGUMS-UHFFFAOYSA-N 0.000 claims 2
- BGBRJHULRSRLSU-UHFFFAOYSA-N 6-[5-[1-(2-cyanoacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CC#N)=C1 BGBRJHULRSRLSU-UHFFFAOYSA-N 0.000 claims 2
- MFBQCYAYAPGPCB-UHFFFAOYSA-N 6-[5-[1-(cyclopropanecarbonyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)C2CC2)=C1 MFBQCYAYAPGPCB-UHFFFAOYSA-N 0.000 claims 2
- XQNBHDOKYLYLNK-UHFFFAOYSA-N 6-[5-[1-(ethylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)NCC)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 XQNBHDOKYLYLNK-UHFFFAOYSA-N 0.000 claims 2
- WYNDXPACGFLUGD-UHFFFAOYSA-N 6-[5-[1-[2-(cyclopropylamino)-2-oxoethyl]-6-oxopyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(CC(=O)NC3CC3)C(=O)C=C2)=C1 WYNDXPACGFLUGD-UHFFFAOYSA-N 0.000 claims 2
- QVKBAQDUWARSNI-UHFFFAOYSA-N 6-[5-[5-chloro-1-[2-(methylamino)-2-oxoethyl]-6-oxopyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(Cl)C(=O)N(CC(=O)NC)C=C1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 QVKBAQDUWARSNI-UHFFFAOYSA-N 0.000 claims 2
- JOXMIWKXJWNRTP-ZTBHGZPVSA-N O[C@H](C(=O)NC1CCC(CC1)C1C(=NOC1)C=1C(=NC(=NC=1)C)C(=O)N)C Chemical compound O[C@H](C(=O)NC1CCC(CC1)C1C(=NOC1)C=1C(=NC(=NC=1)C)C(=O)N)C JOXMIWKXJWNRTP-ZTBHGZPVSA-N 0.000 claims 2
- 125000006392 alkylpyrimidinyl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000002785 azepinyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 claims 2
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 2
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- ZLTRUCOVZUWPBM-UJUVCNOISA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C3OCCOC3=CC=2)O[C@H](CO)CO1 ZLTRUCOVZUWPBM-UJUVCNOISA-N 0.000 claims 2
- ZLTRUCOVZUWPBM-KBJGYGKASA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C3OCCOC3=CC=2)O[C@H](CO)CO1 ZLTRUCOVZUWPBM-KBJGYGKASA-N 0.000 claims 2
- KPQDSKFVSZMAJO-URZJWIJPSA-N n-(2,3-dihydro-1-benzofuran-5-ylmethyl)-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C3CCOC3=CC=2)O[C@H](CO)CO1 KPQDSKFVSZMAJO-URZJWIJPSA-N 0.000 claims 2
- WPRXUJFABHKJIO-SMHULIPUSA-N n-[(3,4-dichlorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(Cl)=CC=2)O[C@H](CO)CO1 WPRXUJFABHKJIO-SMHULIPUSA-N 0.000 claims 2
- NZNCGDUQFWKCEB-SMHULIPUSA-N n-[(3,4-difluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C(F)=CC=2)O[C@H](CO)CO1 NZNCGDUQFWKCEB-SMHULIPUSA-N 0.000 claims 2
- NZNCGDUQFWKCEB-CAYVGHNUSA-N n-[(3,4-difluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C(F)=CC=2)O[C@H](CO)CO1 NZNCGDUQFWKCEB-CAYVGHNUSA-N 0.000 claims 2
- POCGPTVKWWVDHU-SMHULIPUSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@H](CO)CO1 POCGPTVKWWVDHU-SMHULIPUSA-N 0.000 claims 2
- ZSOZNSMQLIIHBO-UHFFFAOYSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=C(Cl)C(F)=CC=2)=CC=1C(C1)=NOC1C1=CC=C(C#N)N=N1 ZSOZNSMQLIIHBO-UHFFFAOYSA-N 0.000 claims 2
- NFMUXCPSAQLIPX-CDHQVMDDSA-N n-[(3-fluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C=CC=2)O[C@H](CO)CO1 NFMUXCPSAQLIPX-CDHQVMDDSA-N 0.000 claims 2
- NFMUXCPSAQLIPX-UIAACRFSSA-N n-[(3-fluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(F)C=CC=2)O[C@H](CO)CO1 NFMUXCPSAQLIPX-UIAACRFSSA-N 0.000 claims 2
- NJONGVJOBWDJFQ-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-(5-pyridin-3-yl-4,5-dihydro-1h-pyrazol-3-yl)pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(NN=2)C=2C=NC=CC=2)=C1 NJONGVJOBWDJFQ-UHFFFAOYSA-N 0.000 claims 2
- CRMHCCJNEYVRPY-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]pyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(CC(=O)NC(C)C)C(=O)C=C2)=C1 CRMHCCJNEYVRPY-UHFFFAOYSA-N 0.000 claims 2
- MYYHERXNVLQLPV-UJUVCNOISA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(methoxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](COC)CO[C@H]1[C@@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 MYYHERXNVLQLPV-UJUVCNOISA-N 0.000 claims 2
- VUMINWLDNHKRNZ-DLPLYFIVSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 VUMINWLDNHKRNZ-DLPLYFIVSA-N 0.000 claims 2
- MYYHERXNVLQLPV-KBJGYGKASA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(methoxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1O[C@H](COC)CO[C@H]1[C@H]1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 MYYHERXNVLQLPV-KBJGYGKASA-N 0.000 claims 2
- HUBSMBFUBXCXEA-UZFJHSOTSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-[[(2-hydroxy-2-methylpropanoyl)amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)C(C)(C)O)OC2)=C1 HUBSMBFUBXCXEA-UZFJHSOTSA-N 0.000 claims 2
- UIDMPBQFXUBJBM-BDTNDASRSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5s)-5-(2-hydroxypropan-2-yl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@H](OC2)C(C)(C)O)=C1 UIDMPBQFXUBJBM-BDTNDASRSA-N 0.000 claims 2
- SSORJRCSPSSGJH-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxyethyl)-6-oxopyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(CCO)C(=O)C=C2)=C1 SSORJRCSPSSGJH-UHFFFAOYSA-N 0.000 claims 2
- GRCFFZIUCALRRH-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxyethylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)NCCO)=C1 GRCFFZIUCALRRH-UHFFFAOYSA-N 0.000 claims 2
- IWQHLJXMUPIVSX-IPHXSNPTSA-N n-[(4-fluoro-3-methylphenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(C)C(F)=CC=2)O[C@H](CO)CO1 IWQHLJXMUPIVSX-IPHXSNPTSA-N 0.000 claims 2
- CDVGIXMNPDEFMY-CDHQVMDDSA-N n-[(4-fluorophenyl)methyl]-6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@H](CO)CO1 CDVGIXMNPDEFMY-CDHQVMDDSA-N 0.000 claims 2
- CDVGIXMNPDEFMY-UIAACRFSSA-N n-[(4-fluorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@H](CO)CO1 CDVGIXMNPDEFMY-UIAACRFSSA-N 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 2
- 125000005888 tetrahydroindolyl group Chemical group 0.000 claims 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
- DVVGIUUJYPYENY-UHFFFAOYSA-N 1-methylpyridin-2-one Chemical compound CN1C=CC=CC1=O DVVGIUUJYPYENY-UHFFFAOYSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- PKMYPARGAZZRPU-UHFFFAOYSA-N 3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C(N)=O)=C1 PKMYPARGAZZRPU-UHFFFAOYSA-N 0.000 claims 1
- HSIFWXRIRBCVSN-UHFFFAOYSA-N 3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-n-(2-hydroxyethyl)-4,5-dihydro-1,2-oxazole-5-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C(=O)NCCO)=C1 HSIFWXRIRBCVSN-UHFFFAOYSA-N 0.000 claims 1
- QUKFOEYYERLLHD-UHFFFAOYSA-N 4-[3-[2-[(3-methoxyphenyl)methylcarbamoyl]pyridin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]benzoic acid Chemical compound COC1=CC=CC(CNC(=O)C=2N=CC=C(C=2)C=2CC(ON=2)C=2C=CC(=CC=2)C(O)=O)=C1 QUKFOEYYERLLHD-UHFFFAOYSA-N 0.000 claims 1
- FUUJBNDEKUZXDE-UHFFFAOYSA-N 4-[3-[2-[(4-methoxyphenyl)methylcarbamoyl]pyridin-4-yl]-4,5-dihydro-1,2-oxazol-5-yl]benzoic acid Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(=CC=2)C(O)=O)=CC=N1 FUUJBNDEKUZXDE-UHFFFAOYSA-N 0.000 claims 1
- YEYDUPQIDIQSMF-UHFFFAOYSA-N 6-(5-cyano-4,5-dihydro-1,2-oxazol-3-yl)-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C#N)=C1 YEYDUPQIDIQSMF-UHFFFAOYSA-N 0.000 claims 1
- KIHSELXDJPJAOY-UHFFFAOYSA-N 6-(5-cyclohexyl-4,5-dihydro-1,2-oxazol-3-yl)-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCCCC2)=C1 KIHSELXDJPJAOY-UHFFFAOYSA-N 0.000 claims 1
- KHBLMURYLWZVDR-JOCHJYFZSA-N 6-[(5r)-5-(1-cyclopropyl-6-oxopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)C2=CN(C(=O)C=C2)C2CC2)=C1 KHBLMURYLWZVDR-JOCHJYFZSA-N 0.000 claims 1
- UBIRUTGOXKERES-MAODMQOUSA-N 6-[(5r)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-MAODMQOUSA-N 0.000 claims 1
- FBHBZYVPGXBFMY-DQLDELGASA-N 6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 FBHBZYVPGXBFMY-DQLDELGASA-N 0.000 claims 1
- UBIRUTGOXKERES-DQLDELGASA-N 6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@@H](ON=2)[C@H]2OC[C@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-DQLDELGASA-N 0.000 claims 1
- LQVNBOCRYMDTLX-KBJGYGKASA-N 6-[(5s)-5-[(2r,5r)-5-(cyanomethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CC#N)OC2)=C1 LQVNBOCRYMDTLX-KBJGYGKASA-N 0.000 claims 1
- FBHBZYVPGXBFMY-TYCQWZJGSA-N 6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 FBHBZYVPGXBFMY-TYCQWZJGSA-N 0.000 claims 1
- UBIRUTGOXKERES-TYCQWZJGSA-N 6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-TYCQWZJGSA-N 0.000 claims 1
- FBHBZYVPGXBFMY-NDXORKPFSA-N 6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@H]2OC[C@H](CO)OC2)=C1 FBHBZYVPGXBFMY-NDXORKPFSA-N 0.000 claims 1
- UBIRUTGOXKERES-NDXORKPFSA-N 6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2C[C@H](ON=2)[C@H]2OC[C@H](CO)OC2)=NC(C)=N1 UBIRUTGOXKERES-NDXORKPFSA-N 0.000 claims 1
- YNCUASCNSKFXMT-UHFFFAOYSA-N 6-[3-[4-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-5-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(OC)=CC=C1CNC(=O)C1=CC(C2ON=C(C2)C=2C=CC(OCCO)=CC=2)=NC(C)=N1 YNCUASCNSKFXMT-UHFFFAOYSA-N 0.000 claims 1
- ABUXLUNBTKCHMK-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3,4-difluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(F)C(F)=CC=2)C1 ABUXLUNBTKCHMK-UHFFFAOYSA-N 0.000 claims 1
- YMPRAPBOGNDAMB-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-chloro-4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(Cl)C(F)=CC=2)C1 YMPRAPBOGNDAMB-UHFFFAOYSA-N 0.000 claims 1
- VMIMWYZCKROPHO-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(C)=O)=C1 VMIMWYZCKROPHO-UHFFFAOYSA-N 0.000 claims 1
- OCDKNHLPRQKXSM-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(C)=O)=C1 OCDKNHLPRQKXSM-UHFFFAOYSA-N 0.000 claims 1
- BZKGWGRWLCPLCT-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methylphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(C)C(F)=CC=2)C1 BZKGWGRWLCPLCT-UHFFFAOYSA-N 0.000 claims 1
- BCNZDERMXCGBAG-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluorophenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(C(=O)C)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=CC(F)=CC=2)C1 BCNZDERMXCGBAG-UHFFFAOYSA-N 0.000 claims 1
- IMIWNHDFOKMDEV-UHFFFAOYSA-N 6-[5-(1-acetylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C2CCN(CC2)C(C)=O)=NC(C)=N1 IMIWNHDFOKMDEV-UHFFFAOYSA-N 0.000 claims 1
- BSUOXCWNKFVSGN-UHFFFAOYSA-N 6-[5-(1-cyclopropyl-6-oxopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=NN(C(=O)C=C2)C2CC2)=C1 BSUOXCWNKFVSGN-UHFFFAOYSA-N 0.000 claims 1
- HFZLZQLYMOWBMA-UHFFFAOYSA-N 6-[5-(1-cyclopropylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C2CC2)=C1 HFZLZQLYMOWBMA-UHFFFAOYSA-N 0.000 claims 1
- TUDAPIPJLPXVSX-UHFFFAOYSA-N 6-[5-(1-ethylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1CN(S(=O)(=O)CC)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 TUDAPIPJLPXVSX-UHFFFAOYSA-N 0.000 claims 1
- UOXQXLLIMOYXAT-UHFFFAOYSA-N 6-[5-(2-carbamoylpyridin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C(N=CC=2)C(N)=O)=C1 UOXQXLLIMOYXAT-UHFFFAOYSA-N 0.000 claims 1
- QIQWUPWKRUDLNC-UHFFFAOYSA-N 6-[5-(3-carbamoylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C(C=CC=2)C(N)=O)=C1 QIQWUPWKRUDLNC-UHFFFAOYSA-N 0.000 claims 1
- QZFVQZANCFRQMP-UHFFFAOYSA-N 6-[5-(4-carbamoylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=CC(=CC=2)C(N)=O)=C1 QZFVQZANCFRQMP-UHFFFAOYSA-N 0.000 claims 1
- DWZUMKXSEWDFCI-UHFFFAOYSA-N 6-[5-(4-carbamoylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(=CC=2)C(N)=O)=NC(C)=N1 DWZUMKXSEWDFCI-UHFFFAOYSA-N 0.000 claims 1
- JKNBTFSEKUNTHE-UHFFFAOYSA-N 6-[5-(4-methoxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(OC)=CC=2)=NC(C)=N1 JKNBTFSEKUNTHE-UHFFFAOYSA-N 0.000 claims 1
- DLQIWQIRMNSNGU-UHFFFAOYSA-N 6-[5-(5-acetylpyridin-2-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CC(=CC=2)C(C)=O)=C1 DLQIWQIRMNSNGU-UHFFFAOYSA-N 0.000 claims 1
- BBZOBIVRJKEVKD-UHFFFAOYSA-N 6-[5-(5-carbamoyl-2-methylpyrazol-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N(N=C(C=2)C(N)=O)C)=C1 BBZOBIVRJKEVKD-UHFFFAOYSA-N 0.000 claims 1
- QTKSHIASVPMECN-UHFFFAOYSA-N 6-[5-(5-cyanopyridin-2-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CC(=CC=2)C#N)=C1 QTKSHIASVPMECN-UHFFFAOYSA-N 0.000 claims 1
- IZIQZKUMHFLYHL-UHFFFAOYSA-N 6-[5-(6-cyanopyridazin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=NC(=CC=2)C#N)=C1 IZIQZKUMHFLYHL-UHFFFAOYSA-N 0.000 claims 1
- YSIHNPGXCFXGAO-UHFFFAOYSA-N 6-[5-(6-cyanopyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=NC(=CC=2)C#N)=C1 YSIHNPGXCFXGAO-UHFFFAOYSA-N 0.000 claims 1
- DKAATJPTQGKKPT-UHFFFAOYSA-N 6-[5-(bromomethyl)-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CBr)ON=2)=C1 DKAATJPTQGKKPT-UHFFFAOYSA-N 0.000 claims 1
- GWZCVMZPNCJAHM-UHFFFAOYSA-N 6-[5-[(1-acetylpiperidin-4-yl)methyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CC3CCN(CC3)C(C)=O)ON=2)=C1 GWZCVMZPNCJAHM-UHFFFAOYSA-N 0.000 claims 1
- FBHBZYVPGXBFMY-PMYDAVCKSA-N 6-[5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)[C@@H]2OC[C@@H](CO)OC2)=C1 FBHBZYVPGXBFMY-PMYDAVCKSA-N 0.000 claims 1
- BDOLFGRFWDZWQK-UHFFFAOYSA-N 6-[5-[(4-acetylpiperazin-1-yl)methyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CN3CCN(CC3)C(C)=O)ON=2)=C1 BDOLFGRFWDZWQK-UHFFFAOYSA-N 0.000 claims 1
- UPOLDGMCGLSOPT-UHFFFAOYSA-N 6-[5-[1-(1,2-dimethylimidazol-4-yl)sulfonylpiperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C=2N=C(C)N(C)C=2)=C1 UPOLDGMCGLSOPT-UHFFFAOYSA-N 0.000 claims 1
- IOOZZRLZGLMCDB-UHFFFAOYSA-N 6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CO)=C1 IOOZZRLZGLMCDB-UHFFFAOYSA-N 0.000 claims 1
- TYYNEHSCVIZISN-UHFFFAOYSA-N 6-[5-[1-(cyclobutanecarbonyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)C2CCC2)=C1 TYYNEHSCVIZISN-UHFFFAOYSA-N 0.000 claims 1
- VMYCKPMBUIXAEQ-UHFFFAOYSA-N 6-[5-[1-(dimethylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)N(C)C)=C1 VMYCKPMBUIXAEQ-UHFFFAOYSA-N 0.000 claims 1
- LVNYZRAMRUBUKL-UHFFFAOYSA-N 6-[5-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C2=C(ON=C2C)C)=C1 LVNYZRAMRUBUKL-UHFFFAOYSA-N 0.000 claims 1
- CJFYPZINDJIFND-UHFFFAOYSA-N 6-[5-[1-[2-(dimethylamino)-2-oxoethyl]-2-oxopyridin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CC(=O)N(CC(=O)N(C)C)C=C2)=C1 CJFYPZINDJIFND-UHFFFAOYSA-N 0.000 claims 1
- KUSVSYIDZUCJSF-UHFFFAOYSA-N 6-[5-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CN(C)C)=C1 KUSVSYIDZUCJSF-UHFFFAOYSA-N 0.000 claims 1
- JLPVTKZIJFLXMA-UHFFFAOYSA-N 6-[5-[1-[3-(dimethylamino)propanoyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CCN(C)C)=C1 JLPVTKZIJFLXMA-UHFFFAOYSA-N 0.000 claims 1
- DJQPQHURFAAVGN-UHFFFAOYSA-N 6-[5-[3-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=C(OCCO)C=CC=2)=NC(C)=N1 DJQPQHURFAAVGN-UHFFFAOYSA-N 0.000 claims 1
- IYLGFEORMHWKGV-UHFFFAOYSA-N 6-[5-[4-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(OCCO)=CC=2)=NC(C)=N1 IYLGFEORMHWKGV-UHFFFAOYSA-N 0.000 claims 1
- PSUBTMAPVXCDPK-UHFFFAOYSA-N 6-[5-[4-(2-hydroxyethoxy)phenyl]-5-methyl-4h-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(C)(ON=2)C=2C=CC(OCCO)=CC=2)=NC(C)=N1 PSUBTMAPVXCDPK-UHFFFAOYSA-N 0.000 claims 1
- CYFFMARQRZWDLL-UHFFFAOYSA-N 6-[5-[4-(dimethylamino)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(=CC=2)N(C)C)=NC(C)=N1 CYFFMARQRZWDLL-UHFFFAOYSA-N 0.000 claims 1
- DTZCBHGHKXIGNI-UHFFFAOYSA-N 6-[5-[4-(hydroxymethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC(CO)=CC=2)=NC(C)=N1 DTZCBHGHKXIGNI-UHFFFAOYSA-N 0.000 claims 1
- IKSXVZQIJQZEEI-UHFFFAOYSA-N 6-[5-[4-(hydroxymethyl)phenyl]-5-methyl-4h-1,2-oxazol-3-yl]-n-[(4-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(C)(ON=2)C=2C=CC(CO)=CC=2)=NC(C)=N1 IKSXVZQIJQZEEI-UHFFFAOYSA-N 0.000 claims 1
- KOSVWFMXGQDBEG-UHFFFAOYSA-N 6-[5-[6-(dimethylamino)pyridazin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=NC(=CC=2)N(C)C)=C1 KOSVWFMXGQDBEG-UHFFFAOYSA-N 0.000 claims 1
- SZPWBEHOJDLULG-UHFFFAOYSA-N CC1=NC=C(C(C2)=NOC2C(C=CN2C3CC3)=CC2=O)C(C(NCC(C=C2)=CC(OC)=C2F)=O)=N1 Chemical compound CC1=NC=C(C(C2)=NOC2C(C=CN2C3CC3)=CC2=O)C(C(NCC(C=C2)=CC(OC)=C2F)=O)=N1 SZPWBEHOJDLULG-UHFFFAOYSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- GRKWOBDTMOXZDO-UHFFFAOYSA-N N1=C(C=CC=C1)C(=O)NC1=NOC(C1)C1=CC=C(C=C1)OC Chemical compound N1=C(C=CC=C1)C(=O)NC1=NOC(C1)C1=CC=C(C=C1)OC GRKWOBDTMOXZDO-UHFFFAOYSA-N 0.000 claims 1
- JKBBPBQSMCPUHV-UHFFFAOYSA-N N1=CN=C(C=C1)C(=O)NC1=NOC(C1)C1CCN(CC1)S(=O)(=O)CCC Chemical compound N1=CN=C(C=C1)C(=O)NC1=NOC(C1)C1CCN(CC1)S(=O)(=O)CCC JKBBPBQSMCPUHV-UHFFFAOYSA-N 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- 230000000975 bioactive effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- QFUANYPJSKONLS-UHFFFAOYSA-N methyl 3-[6-[(4-fluoro-3-methoxyphenyl)methylcarbamoyl]-2-methylpyrimidin-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylate Chemical compound O1C(C(=O)OC)CC(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)=N1 QFUANYPJSKONLS-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 claims 1
- WPRXUJFABHKJIO-CAYVGHNUSA-N n-[(3,4-dichlorophenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(Cl)=CC=2)O[C@H](CO)CO1 WPRXUJFABHKJIO-CAYVGHNUSA-N 0.000 claims 1
- PNMSJCNGUJWZSY-UHFFFAOYSA-N n-[(3,4-difluorophenyl)methyl]-6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=C(F)C(F)=CC=2)=CC=1C(C1)=NOC1C1CCN(C(=O)CO)CC1 PNMSJCNGUJWZSY-UHFFFAOYSA-N 0.000 claims 1
- POCGPTVKWWVDHU-SVIJTADQSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@@H](CO)CO1 POCGPTVKWWVDHU-SVIJTADQSA-N 0.000 claims 1
- POCGPTVKWWVDHU-MRFFXTKBSA-N n-[(3-chloro-4-fluorophenyl)methyl]-6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(Cl)C(F)=CC=2)O[C@@H](CO)CO1 POCGPTVKWWVDHU-MRFFXTKBSA-N 0.000 claims 1
- CWNRJENDTYRZPH-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-1-methyl-6-oxo-5-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)pyridazine-3-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C2=NN(C)C(=O)C(C=3CC(ON=3)C=3C=CC=CC=3)=C2)=C1 CWNRJENDTYRZPH-UHFFFAOYSA-N 0.000 claims 1
- BXDCMUHKTBMPAZ-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-(5-piperidin-4-yl-4,5-dihydro-1,2-oxazol-3-yl)pyrimidine-4-carboxamide;hydrochloride Chemical compound Cl.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCNCC2)=C1 BXDCMUHKTBMPAZ-UHFFFAOYSA-N 0.000 claims 1
- ZSQFXGZBGLCCKV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1-methylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(C)(=O)=O)=C1 ZSQFXGZBGLCCKV-UHFFFAOYSA-N 0.000 claims 1
- QXCILQPOFXCONT-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1-propan-2-ylsulfonylpiperidin-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)S(=O)(=O)C(C)C)=C1 QXCILQPOFXCONT-UHFFFAOYSA-N 0.000 claims 1
- LPELAXBWOYQRGR-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1h-pyrazol-4-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CNN=C2)=C1 LPELAXBWOYQRGR-UHFFFAOYSA-N 0.000 claims 1
- WHZUKRXYHUFFHD-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(1h-pyrazolo[3,4-b]pyridin-5-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C3C=NNC3=NC=2)=C1 WHZUKRXYHUFFHD-UHFFFAOYSA-N 0.000 claims 1
- ZGULZVKQCWADOX-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(2h-tetrazol-5-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=NNN=N2)=C1 ZGULZVKQCWADOX-UHFFFAOYSA-N 0.000 claims 1
- AVLTXGCYJSINCV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-(6-oxo-1-propan-2-ylpyridin-3-yl)-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2=CN(C(=O)C=C2)C(C)C)=C1 AVLTXGCYJSINCV-UHFFFAOYSA-N 0.000 claims 1
- BKGRYZLVDRTDQV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[1-(1,2-oxazol-3-ylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)NC2=NOC=C2)=C1 BKGRYZLVDRTDQV-UHFFFAOYSA-N 0.000 claims 1
- WZVDBIOGJCLMLB-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[1-(methylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1CN(C(=O)NC)CCC1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 WZVDBIOGJCLMLB-UHFFFAOYSA-N 0.000 claims 1
- GNMHRHIBXLKJFV-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[1-(propan-2-ylcarbamoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)NC(C)C)=C1 GNMHRHIBXLKJFV-UHFFFAOYSA-N 0.000 claims 1
- UOXUDWLNTJLETM-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-2-methyl-6-[5-[6-(methylcarbamoyl)pyridazin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]pyrimidine-4-carboxamide Chemical compound N1=NC(C(=O)NC)=CC=C1C1ON=C(C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)C1 UOXUDWLNTJLETM-UHFFFAOYSA-N 0.000 claims 1
- QRTWNVYTNYIGHX-KBJGYGKASA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-[[(2-hydroxyacetyl)amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)CO)OC2)=C1 QRTWNVYTNYIGHX-KBJGYGKASA-N 0.000 claims 1
- LOIDEQYZUZFJCU-PHAMGYDHSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-[[[(2s)-2-hydroxypropanoyl]amino]methyl]-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2C[C@H](ON=2)[C@@H]2OC[C@@H](CNC(=O)[C@H](C)O)OC2)=C1 LOIDEQYZUZFJCU-PHAMGYDHSA-N 0.000 claims 1
- GZEVFPQEYSSLOA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[3-[4-(2-hydroxyethoxy)phenyl]-4,5-dihydro-1,2-oxazol-5-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C2ON=C(C2)C=2C=CC(OCCO)=CC=2)=C1 GZEVFPQEYSSLOA-UHFFFAOYSA-N 0.000 claims 1
- VTRGFTVUYJYTRK-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-(1h-imidazol-5-yl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CNC=2)=C1 VTRGFTVUYJYTRK-UHFFFAOYSA-N 0.000 claims 1
- XDESZNJZNUNRPA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-(4-hydroxycyclohexyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCC(O)CC2)=C1 XDESZNJZNUNRPA-UHFFFAOYSA-N 0.000 claims 1
- HVUBKDBTMMRZID-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(1-methoxyethyl)-2-oxopyridin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound O=C1N(C(C)OC)C=CC(C2ON=C(C2)C=2N=C(C)N=C(C=2)C(=O)NCC=2C=C(OC)C(F)=CC=2)=C1 HVUBKDBTMMRZID-UHFFFAOYSA-N 0.000 claims 1
- XEVQTPDDBAWNMF-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)C(C)(C)O)=C1 XEVQTPDDBAWNMF-UHFFFAOYSA-N 0.000 claims 1
- QVSDJBBXQLHZKR-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)CO)=C1 QVSDJBBXQLHZKR-UHFFFAOYSA-N 0.000 claims 1
- GJSIEEKUUHNEEL-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[1-[2-hydroxyethyl(methyl)carbamoyl]piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C2CCN(CC2)C(=O)N(C)CCO)=C1 GJSIEEKUUHNEEL-UHFFFAOYSA-N 0.000 claims 1
- VOTXJESWASBGSA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[2-(2-hydroxypropan-2-yl)pyridin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=C(N=CC=2)C(C)(C)O)=C1 VOTXJESWASBGSA-UHFFFAOYSA-N 0.000 claims 1
- LZEVBBPDPFANJA-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[4-(hydroxymethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=CC(CO)=CC=2)=C1 LZEVBBPDPFANJA-UHFFFAOYSA-N 0.000 claims 1
- OEZVJYXHTCCFRL-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[4-[4-(hydroxymethyl)piperidin-1-yl]phenyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=CC(=CC=2)N2CCC(CO)CC2)=C1 OEZVJYXHTCCFRL-UHFFFAOYSA-N 0.000 claims 1
- ATOKUWJNXHKBKF-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[5-(hydroxymethyl)pyridin-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2N=CC(CO)=CC=2)=C1 ATOKUWJNXHKBKF-UHFFFAOYSA-N 0.000 claims 1
- JXVWNRROGBHPCT-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[6-(hydroxymethyl)pyridin-3-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(ON=2)C=2C=NC(CO)=CC=2)=C1 JXVWNRROGBHPCT-UHFFFAOYSA-N 0.000 claims 1
- BWKAGPPKRMXSFJ-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[[1-(2-hydroxyacetyl)piperidin-4-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CC3CCN(CC3)C(=O)CO)ON=2)=C1 BWKAGPPKRMXSFJ-UHFFFAOYSA-N 0.000 claims 1
- IGWVIUCEGBUSEI-UHFFFAOYSA-N n-[(4-fluoro-3-methoxyphenyl)methyl]-6-[5-[[3-(hydroxymethyl)pyrrolidin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(OC)=CC(CNC(=O)C=2N=C(C)N=C(C=2)C=2CC(CN3CC(CO)CC3)ON=2)=C1 IGWVIUCEGBUSEI-UHFFFAOYSA-N 0.000 claims 1
- IWQHLJXMUPIVSX-GQWLDOHISA-N n-[(4-fluoro-3-methylphenyl)methyl]-6-[(5s)-5-[(2r,5r)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=C(C)C(F)=CC=2)O[C@H](CO)CO1 IWQHLJXMUPIVSX-GQWLDOHISA-N 0.000 claims 1
- CDVGIXMNPDEFMY-BEVDRBHNSA-N n-[(4-fluorophenyl)methyl]-6-[(5r)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@@H](CO)CO1 CDVGIXMNPDEFMY-BEVDRBHNSA-N 0.000 claims 1
- CDVGIXMNPDEFMY-YSSFQJQWSA-N n-[(4-fluorophenyl)methyl]-6-[(5s)-5-[(2s,5s)-5-(hydroxymethyl)-1,4-dioxan-2-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound C([C@H]1[C@H]2ON=C(C2)C=2C=C(N=C(N=2)C)C(=O)NCC=2C=CC(F)=CC=2)O[C@@H](CO)CO1 CDVGIXMNPDEFMY-YSSFQJQWSA-N 0.000 claims 1
- RUUISHLXIGXBOL-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-6-[5-[1-(2-hydroxyacetyl)piperidin-4-yl]-4,5-dihydro-1,2-oxazol-3-yl]-2-methylpyrimidine-4-carboxamide Chemical compound N=1C(C)=NC(C(=O)NCC=2C=CC(F)=CC=2)=CC=1C(C1)=NOC1C1CCN(C(=O)CO)CC1 RUUISHLXIGXBOL-UHFFFAOYSA-N 0.000 claims 1
- FALVPVBUAZQTAT-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-2-methyl-6-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)pyrimidine-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC(C=2CC(ON=2)C=2C=CC=CC=2)=NC(C)=N1 FALVPVBUAZQTAT-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- YPOXGDJGKBXRFP-UHFFFAOYSA-N pyrimidine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC=N1 YPOXGDJGKBXRFP-UHFFFAOYSA-N 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1272DE2011 | 2011-04-30 | ||
| IN1272/DEL/2011 | 2011-04-30 | ||
| PCT/US2012/035832 WO2012151158A1 (en) | 2011-04-30 | 2012-04-30 | Isoxazolines as therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513122A JP2014513122A (ja) | 2014-05-29 |
| JP2014513122A5 true JP2014513122A5 (enExample) | 2015-06-25 |
| JP6101250B2 JP6101250B2 (ja) | 2017-03-22 |
Family
ID=47108012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509340A Expired - Fee Related JP6101250B2 (ja) | 2011-04-30 | 2012-04-30 | 治療薬としてのイソオキサゾリン類 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9029409B2 (enExample) |
| EP (1) | EP2704712A4 (enExample) |
| JP (1) | JP6101250B2 (enExample) |
| KR (1) | KR20140041512A (enExample) |
| CN (1) | CN103764145A (enExample) |
| AR (1) | AR086113A1 (enExample) |
| AU (2) | AU2012250979B2 (enExample) |
| CA (1) | CA2834237A1 (enExample) |
| CL (1) | CL2013003125A1 (enExample) |
| CO (1) | CO6801765A2 (enExample) |
| CR (1) | CR20130597A (enExample) |
| DO (1) | DOP2013000251A (enExample) |
| EC (1) | ECSP13013026A (enExample) |
| GT (1) | GT201300267A (enExample) |
| IL (1) | IL229081A0 (enExample) |
| MX (1) | MX355996B (enExample) |
| MY (1) | MY163870A (enExample) |
| PE (1) | PE20141190A1 (enExample) |
| PH (2) | PH12013502218A1 (enExample) |
| RU (1) | RU2013152961A (enExample) |
| SG (1) | SG194696A1 (enExample) |
| TW (1) | TW201247657A (enExample) |
| UY (1) | UY34043A (enExample) |
| WO (1) | WO2012151158A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2916805T3 (es) * | 2012-11-21 | 2022-07-06 | Zoetis Services Llc | Síntesis de derivados de isoxazolina espirocíclicos |
| US20150065724A1 (en) * | 2013-09-05 | 2015-03-05 | Abbvie Inc. | Diastereoselective methods for synthesizing compounds |
| EP3325465B1 (en) * | 2015-07-17 | 2022-05-18 | Syngenta Participations AG | Pesticidally active pyrazole derivatives |
| EP3145168A1 (en) | 2015-09-17 | 2017-03-22 | Thomson Licensing | An apparatus and a method for generating data representing a pixel beam |
| ES2944616T3 (es) | 2017-08-14 | 2023-06-22 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas |
| EP3847169A1 (en) * | 2018-09-04 | 2021-07-14 | F. Hoffmann-La Roche AG | Benzothiazole compounds for the treatment of autoimmune diseases |
| CA3194203A1 (en) * | 2020-09-14 | 2022-03-17 | Genzyme Corporation | Carboxylic acid-containing compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell disease |
| WO2022233877A1 (en) | 2021-05-03 | 2022-11-10 | Katholieke Universiteit Leuven | Treatment of pharmacoresistant epilepsy |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6090382A (en) | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
| CO5170501A1 (es) | 1999-04-14 | 2002-06-27 | Novartis Ag | AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO |
| ECSP003448A (es) | 2000-04-27 | 2000-05-25 | Azoles sustituidos | |
| AU2003268064A1 (en) | 2002-08-09 | 2004-02-25 | Astrazeneca Ab | Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| US20040067985A1 (en) * | 2002-10-04 | 2004-04-08 | Fortuna Haviv | Method of inhibiting angiogenesis |
| ATE388941T1 (de) | 2002-11-02 | 2008-03-15 | Sanofi Aventis Deutschland | Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen |
| US7166609B2 (en) * | 2002-11-02 | 2007-01-23 | Sanofi-Aventis Deutschland Gmbh | Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases |
| US7125870B2 (en) * | 2002-11-06 | 2006-10-24 | Bristol-Myers Squibb Company | Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| US20050004111A1 (en) * | 2003-01-03 | 2005-01-06 | Aventis Pharma Deutschland Gmbh | Selective MMP-13 inhibitors |
| US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
| WO2005070891A2 (en) | 2004-01-23 | 2005-08-04 | Amgen Inc | Compounds and methods of use |
| CN1930136B (zh) | 2004-03-05 | 2012-02-08 | 日产化学工业株式会社 | 异*唑啉取代苯甲酰胺化合物及有害生物防除剂 |
| DE102004023635A1 (de) | 2004-05-10 | 2006-04-13 | Grünenthal GmbH | Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate |
| TWI422376B (zh) * | 2005-01-25 | 2014-01-11 | Synta Pharmaceuticals Corp | 用於炎症及免疫相關用途之化合物 |
| ES2376642T3 (es) | 2005-08-15 | 2012-03-15 | F. Hoffmann-La Roche Ag | Derivados de piperidina y de piperazina como antagonistas del p2x3. |
| US7964624B1 (en) | 2005-08-26 | 2011-06-21 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases |
| CN101330828A (zh) * | 2005-12-14 | 2008-12-24 | 杜邦公司 | 用于防治无脊椎害虫的异噁唑啉 |
| EP1965645A2 (en) * | 2005-12-14 | 2008-09-10 | E.I. Du Pont De Nemours And Company | Isoxazolines for controlling invertebrate pests |
| JP2009519208A (ja) | 2005-12-15 | 2009-05-14 | 塩野義製薬株式会社 | アミド誘導体を含有する医薬組成物 |
| TWI412322B (zh) * | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| CA2635580A1 (en) * | 2005-12-30 | 2007-07-12 | Alantos Pharmaceuticals Holding, Inc. | Substituted bis-amide metalloprotease inhibitors |
| AU2007240954A1 (en) * | 2006-04-20 | 2007-11-01 | E. I. Du Pont De Nemours And Company | Pyrazolines for controlling invertebrate pests |
| ES2804801T3 (es) | 2006-12-26 | 2021-02-09 | Lantheus Medical Imaging Inc | Ligandos para la formación de imágenes de la inervación cardíaca |
| US8623875B2 (en) * | 2007-06-13 | 2014-01-07 | E.I. Du Pont De Nemours And Company | Isoxazoline insecticides |
| US20090035381A1 (en) | 2007-08-01 | 2009-02-05 | Stankus John J | Electrospraying method for fabrication of particles and coatings and treatment methods thereof |
| MX2010001338A (es) * | 2007-08-02 | 2010-04-21 | Pfizer | Derivados de pirimidina y piridina y su uso y composiciones farmaceuticas. |
| US8288393B2 (en) | 2007-08-10 | 2012-10-16 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic compound and pest control agent |
| US8168114B2 (en) | 2007-09-12 | 2012-05-01 | University Of Washington Through Its Center For Commercialization | Methods for blow molding solid-state cellular thermoplastic articles |
| ES2553412T3 (es) | 2007-10-31 | 2015-12-09 | Merck Sharp & Dohme Corp. | Antagonistas del receptor P2X3 para el tratamiento del dolor |
| TWI411395B (zh) * | 2007-12-24 | 2013-10-11 | Syngenta Participations Ag | 殺蟲化合物 |
| JP2009286773A (ja) | 2008-03-14 | 2009-12-10 | Bayer Cropscience Ag | 殺虫性縮環式アリール類 |
| NZ588954A (en) | 2008-05-01 | 2012-08-31 | Vitae Pharmaceuticals Inc | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| HUE028347T2 (en) | 2008-06-10 | 2016-12-28 | Abbvie Inc | Tricyclic compounds |
| WO2010010187A1 (en) | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| WO2010020522A1 (en) * | 2008-08-22 | 2010-02-25 | Syngenta Participations Ag | Insecticidal compounds |
| WO2010045191A2 (en) | 2008-10-13 | 2010-04-22 | Vuelogic, Llc | Methods and systems for customer performance scoring |
| WO2010045190A1 (en) | 2008-10-15 | 2010-04-22 | Boehringer Ingelheim International Gmbh | Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| EP2358371B1 (en) | 2008-10-31 | 2015-02-11 | Merck Sharp & Dohme Corp. | P2x3, receptor antagonists for treatment of pain |
| RU2518462C2 (ru) * | 2008-12-19 | 2014-06-10 | Новартис Аг | Органические соединения |
| CN102292331A (zh) | 2009-01-22 | 2011-12-21 | 先正达参股股份有限公司 | 杀虫化合物 |
| EP2414353A1 (en) * | 2009-04-01 | 2012-02-08 | Basf Se | Isoxazoline compounds for combating invertebrate pests |
| WO2010116282A1 (en) | 2009-04-10 | 2010-10-14 | Pfizer Inc. | 4, 5-dihydro-lh-pyrazole compounds and their pharmaceutical uses |
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| FR2948939B1 (fr) | 2009-08-05 | 2013-03-22 | Pf Medicament | Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine |
| TWI487486B (zh) * | 2009-12-01 | 2015-06-11 | Syngenta Participations Ag | 以異唑啉衍生物為主之殺蟲化合物 |
| GB2481118A (en) | 2010-06-09 | 2011-12-14 | Syngenta Participations Ag | Pesticidal mixtures comprising enantiomerically enriched isoxazoline derivatives |
| KR20130089232A (ko) | 2010-06-15 | 2013-08-09 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 안트라닐산 디아미드 유도체 |
| DK178277B1 (da) | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazolinforbindelser til bekæmpelse af fiskelus |
| BR112013020520A2 (pt) * | 2011-02-10 | 2016-07-12 | Novartis Ag | derivados de isoxazolina, composição para o controle de parasitas os compreendendo e uso dos mesmos |
-
2012
- 2012-04-26 AR ARP120101453 patent/AR086113A1/es unknown
- 2012-04-27 UY UY34043A patent/UY34043A/es not_active Application Discontinuation
- 2012-04-30 JP JP2014509340A patent/JP6101250B2/ja not_active Expired - Fee Related
- 2012-04-30 AU AU2012250979A patent/AU2012250979B2/en not_active Ceased
- 2012-04-30 TW TW101115419A patent/TW201247657A/zh unknown
- 2012-04-30 RU RU2013152961/04A patent/RU2013152961A/ru not_active Application Discontinuation
- 2012-04-30 MY MYPI2013702036A patent/MY163870A/en unknown
- 2012-04-30 SG SG2013080379A patent/SG194696A1/en unknown
- 2012-04-30 US US13/460,158 patent/US9029409B2/en active Active
- 2012-04-30 PH PH1/2013/502218A patent/PH12013502218A1/en unknown
- 2012-04-30 KR KR20137031865A patent/KR20140041512A/ko not_active Withdrawn
- 2012-04-30 PE PE2013002428A patent/PE20141190A1/es not_active Application Discontinuation
- 2012-04-30 MX MX2013012686A patent/MX355996B/es active IP Right Grant
- 2012-04-30 EP EP12779959.1A patent/EP2704712A4/en not_active Withdrawn
- 2012-04-30 CN CN201280031389.5A patent/CN103764145A/zh active Pending
- 2012-04-30 WO PCT/US2012/035832 patent/WO2012151158A1/en not_active Ceased
- 2012-04-30 CA CA 2834237 patent/CA2834237A1/en not_active Abandoned
-
2013
- 2013-10-24 IL IL229081A patent/IL229081A0/en unknown
- 2013-10-29 DO DO2013000251A patent/DOP2013000251A/es unknown
- 2013-10-29 CL CL2013003125A patent/CL2013003125A1/es unknown
- 2013-10-30 GT GT201300267A patent/GT201300267A/es unknown
- 2013-10-31 CO CO13258866A patent/CO6801765A2/es unknown
- 2013-11-15 EC ECSP13013026 patent/ECSP13013026A/es unknown
- 2013-11-15 CR CR20130597A patent/CR20130597A/es unknown
-
2015
- 2015-04-27 US US14/696,680 patent/US20150297596A1/en not_active Abandoned
- 2015-10-26 AU AU2015246181A patent/AU2015246181A1/en not_active Abandoned
-
2016
- 2016-05-05 PH PH12016500838A patent/PH12016500838A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014513122A5 (enExample) | ||
| JP6017313B2 (ja) | 化合物および方法 | |
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| ES2629414T3 (es) | Derivados de tiazol | |
| US8981084B2 (en) | Oxadiazole HDAC inhibitors | |
| JP2017512794A5 (enExample) | ||
| JP2020516671A5 (enExample) | ||
| RU2016141646A (ru) | Ингибиторы trka киназы, основанные на них композиции и способы | |
| JP2016523911A5 (enExample) | ||
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| JP2010533158A5 (enExample) | ||
| JP6500010B2 (ja) | 新規ピリジン誘導体 | |
| JP2014525444A5 (enExample) | ||
| JP2018507234A5 (enExample) | ||
| JP2021504443A5 (enExample) | ||
| JP2007510689A5 (enExample) | ||
| JP2011503166A5 (enExample) | ||
| JP2007523142A5 (enExample) | ||
| CA2630269A1 (en) | Inhibitors of diacyglycerol acyltransferase (dgat) | |
| JP2010540462A5 (enExample) | ||
| RU2015111133A (ru) | Ингибиторы тирозинкиназы брутона | |
| TW202045498A (zh) | 作為法尼醇x受體調節劑之經取代雙環化合物 | |
| JP2017523223A5 (enExample) | ||
| RU2013152961A (ru) | Изоксазолины в качестве терапевтических агентов | |
| JP2014523400A5 (enExample) |